- Home
- KYMR vs ATGE Comparison
KYMR vs ATGE Comparison
Compare KYMR & ATGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- ATGE
- Stock Information
- Founded
- KYMR 2015
- ATGE 1987
- Country
- KYMR United States
- ATGE United States
- Employees
- KYMR N/A
- ATGE N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- ATGE Other Consumer Services
- Sector
- KYMR Health Care
- ATGE Consumer Discretionary
- Exchange
- KYMR Nasdaq
- ATGE Nasdaq
- Market Cap
- KYMR 4.7B
- ATGE 5.4B
- IPO Year
- KYMR 2020
- ATGE 1991
- Fundamental
- Price
- KYMR $67.94
- ATGE $93.55
- Analyst Decision
- KYMR Strong Buy
- ATGE Strong Buy
- Analyst Count
- KYMR 19
- ATGE 3
- Target Price
- KYMR $68.95
- ATGE $145.67
- AVG Volume (30 Days)
- KYMR 696.1K
- ATGE 921.0K
- Earning Date
- KYMR 11-04-2025
- ATGE 10-30-2025
- Dividend Yield
- KYMR N/A
- ATGE N/A
- EPS Growth
- KYMR N/A
- ATGE 53.29
- EPS
- KYMR N/A
- ATGE 6.69
- Revenue
- KYMR $43,735,000.00
- ATGE $1,833,178,000.00
- Revenue This Year
- KYMR $60.88
- ATGE $9.83
- Revenue Next Year
- KYMR N/A
- ATGE $6.11
- P/E Ratio
- KYMR N/A
- ATGE $13.91
- Revenue Growth
- KYMR N/A
- ATGE 12.24
- 52 Week Low
- KYMR $19.45
- ATGE $84.79
- 52 Week High
- KYMR $68.80
- ATGE $156.26
- Technical
- Relative Strength Index (RSI)
- KYMR 68.81
- ATGE 29.80
- Support Level
- KYMR $63.86
- ATGE $86.97
- Resistance Level
- KYMR $68.80
- ATGE $98.31
- Average True Range (ATR)
- KYMR 3.52
- ATGE 3.32
- MACD
- KYMR 0.19
- ATGE 0.87
- Stochastic Oscillator
- KYMR 94.07
- ATGE 55.38
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About ATGE Adtalem Global Education Inc.
Adtalem Global Education Inc is an American for-profit educational company that operates various university and educational programs. The company has three segments namely Chamberlain; Walden; and Medical and Veterinary. It derives maximum revenue from Chamberlain segment.